The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $97.46

Today's change-0.22 -0.23%
Updated June 30 4:01 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $97.46

Today's change-0.22 -0.23%
Updated June 30 4:01 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson down (U.S.)$0.22

Johnson & Johnson closed lower Tuesday, dropping (U.S.)$0.22 or 0.23% to (U.S.)$97.46. Over the last five days, shares have lost 2.33% and sit 2.48% above their 52-week low. This security has underperformed the S&P 500 by 12.09% during the last year.

Key company metrics

  • Open(U.S.) $98.43
  • Previous close(U.S.) $97.68
  • High(U.S.) $98.45
  • Low(U.S.) $97.30
  • Bid / Ask-- / --
  • YTD % change-6.80%
  • Volume8,967,911
  • Average volume (10-day)8,059,993
  • Average volume (1-month)7,722,736
  • Average volume (3-month)7,702,541
  • 52-week range(U.S.) $95.10 to (U.S.) $109.49
  • Beta0.56
  • Trailing P/E17.45×
  • P/E 1 year forward15.92×
  • Forward PEG3.19×
  • Indicated annual dividend(U.S.) $3.00
  • Dividend yield3.08%
  • Trailing EPS(U.S.) $5.59
Updated June 30 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.63%

Based on its net profit margin of 21.63%, Johnson & Johnson is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.44%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 29, 201503/29/2015Dec 28, 201412/28/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014
Revenue17,37418,25418,46719,495
Total other revenue--------
Total revenue17,37418,25418,46719,495
Gross profit12,09212,40113,06813,456
Total cost of revenue5,2825,8535,3996,039
Total operating expense11,79915,55111,65713,869
Selling / general / administrative4,8475,8225,4685,481
Research & development1,8992,6352,0232,005
Depreciation / amortization--------
Interest expense (income), net operating138139130128
Unusual expense (income)015604
Other operating expenses, total-4321,016-1,347171
Operating income5,5752,7036,8105,626
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,5752,7036,8105,626
Income after tax4,3202,5214,7494,326
Income tax, total1,2551822,0611,300
Net income4,3202,5214,7494,326
Total adjustments to net income--------
Net income before extra. items4,3202,5214,7494,326
Minority interest--0----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,3202,5214,7494,326
Inc. avail. to common incl. extra. items4,3202,5214,7494,326
Diluted net income4,3202,5214,7494,326
Dilution adjustment--0--0
Diluted weighted average shares2,8262,8422,8642,874
Diluted EPS excluding extraordinary itemsvalue per share1.530.891.661.51
Dividends per sharevalue per share0.700.700.700.70
Diluted normalized EPSvalue per share1.380.372.001.65